Ken Sugimoto

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Venues

Medicine

PloS one

International journal of colorectal disease

BMC gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Satoshi Tamura, Yusuke Asai, Natsuki Ishida, Takahiro Miyazu, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Ustekinumab effectiveness in Crohn's disease with lesions in the intestines. Medicine 103 (15) (2024)
Satoshi Tamura, Yusuke Asai, Natsuki Ishida, Takahiro Miyazu, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Ustekinumab effectiveness in Crohn's disease with lesions in the intestines. Medicine 103 (15) (2024)
Satoshi Tamura, Yusuke Asai, Natsuki Ishida, Takahiro Miyazu, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Ustekinumab effectiveness in Crohn's disease with lesions in the intestines. Medicine 103 (15) (2024)
Natsuki Ishida, Kenichi Takahashi, Yusuke Asai, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Ken Sugimoto
Albumin change predicts failure in ulcerative colitis treated with adalimumab. PloS one 19 (1) (2024)
Natsuki Ishida, Kenichi Takahashi, Yusuke Asai, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Ken Sugimoto
Albumin change predicts failure in ulcerative colitis treated with adalimumab. PloS one 19 (1) (2024)
Satoshi Tamura, Yusuke Asai, Natsuki Ishida, Takahiro Miyazu, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Ustekinumab effectiveness in Crohn's disease with lesions in the intestines. Medicine 103 (15) (2024)
Natsuki Ishida, Kenichi Takahashi, Yusuke Asai, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Ken Sugimoto
Albumin change predicts failure in ulcerative colitis treated with adalimumab. PloS one 19 (1) (2024)
Xiang Gao, Toshimitsu Fujii, Byong Duk Ye, Jen-Wei Chou, Ken Sugimoto, Qian Cao, Kristina Kligys, Kaoru Murakoshi, Dennis Teng, Yafei Zhang, Hiroshi Nakase
Efficacy and safety of risankizumab for Crohn's disease in patients from Asian countries: a post hoc subanalysis of the global phase 3 ADVANCE, MOTIVATE, and FORTIFY studies. Journal of gastroenterology and hepatology (2023)
Takahiro Miyazu, Natsuki Ishida, Yusuke Asai, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Satoshi Baba, Ken Sugimoto
Importance of eosinophilic infiltration of the colonic mucosa in ulcerative colitis patients who are refractory to maintenance therapy: A prospective, single-center study. Medicine 101 (40) (2022)
Natsuki Ishida, Tomoharu Matsuura, Yusuke Asai, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Predicting Ulcerative Colitis Relapse in Clinical Remission With Fecal Immunochemical Occult Blood Test or Prostaglandin E-Major Urinary Metabolite. Clinical and translational gastroenterology 13 (7) (2022)
Natsuki Ishida, Yusuke Asai, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Lymphocyte-to-monocyte ratio is a short-term predictive marker of ulcerative colitis after induction of advanced therapy. Gastroenterology report 10 (2022)
Takahiro Miyazu, Natsuki Ishida, Ryosuke Takano, Satoshi Tamura, Mihoko Yamade, Yasushi Hamaya, Shinya Tani, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Usefulness of the capsule endoscopy Crohn's disease activity index in assessing the necessity of early additional treatment in patients with Crohn's disease in clinical remission. Medicine 100 (29) (2021)
Natsuki Ishida, Tomohiro Higuchi, Takahiro Miyazu, Satoshi Tamura, Satoshi Suzuki, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease. PloS one 16 (4) (2021)
Masaichi Kato, Ken Sugimoto, Kentaro Ikeya, Ryosuke Takano, Ai Matsuura, Takahiro Miyazu, Natsuki Ishida, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Hiroyuki Hanai
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease. PloS one 16 (7) (2021)
Natsuki Ishida, Takahiro Miyazu, Takahiro Suzuki, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Evaluation of the modified Crohn's disease activity index in patients with Crohn disease with enterostomy: A single-center observational study. Medicine 100 (6) (2021)
Natsuki Ishida, Shunya Onoue, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Further research on the clinical relevance of the ulcerative colitis colonoscopic index of severity for predicting 5-year relapse. International journal of colorectal disease 36 (12) (2021)
Natsuki Ishida, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis. Digestive diseases and sciences (2021)
Natsuki Ishida, Takahiro Miyazu, Tomoharu Matsuura, Ryosuke Takano, Satoshi Tamura, Takuma Kagami, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
Effect of ulcerative colitis duration on the usefulness of immunochemical fecal occult blood test result as a disease activity biomarker. International journal of colorectal disease 35 (9) (2020)
Natsuki Ishida, Takahiro Miyazu, Tomohiro Sugiyama, Satoshi Tamura, Takuma Kagami, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto
The effect of early trough level of infliximab on subsequent disease course in patients with Crohn disease: A prospective cohort study. Medicine 99 (29) (2020)
Shinya Ikeda, Takuma Kagami, Shinya Tani, Takahiro Uotani, Mihoko Yamade, Yasushi Hamaya, Yoshifumi Morita, Takanori Sakaguchi, Satoshi Osawa, Ken Sugimoto
Decompressive laparotomy for abdominal compartment syndrome resulting from severe acute pancreatitis: a case report. BMC gastroenterology 19 (1) (2019)
Yosuke Yamada, Ken Sugimoto, Yashiro Yoshizawa, Yoshifumi Arai, Yoshiro Otsuki, Tomio Arai, Yasuyuki Kobayashi, Yoshihiko Sato, Yoshisuke Hosoda
Mesenteric inflammatory veno-occlusive disease occurring during the course of ulcerative colitis: a case report. BMC gastroenterology 18 (1) (2018)

Ken Sugimoto.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ken Sugimoto